Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Sept 1, 2016 9:54:35 GMT -5
The MannKind saga exemplifies Good versus Evil. Alfred Mann spent the majority of his life creating products for the betterment of mankind. Now with his greatest invention Afrezza and Technosphere, Wall Street is determined to bankrupt the company.
|
|
|
|
Post by dictatorsaurus on Sept 1, 2016 9:59:06 GMT -5
Mannkind's problem is not Wallstreet. Their problem is lack of sales and revenue and a very uncertain future.
If/when script numbers increase no argument or FUD can stop the moving train.
Until then they remain a penny stock.
|
|
|
|
Post by myocat on Sept 1, 2016 9:59:41 GMT -5
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Sept 1, 2016 10:13:37 GMT -5
Mannkind's problem is not Wallstreet. Their problem is lack of sales and revenue and a very uncertain future. If/when script numbers increase no argument or FUD can stop the moving train. Until then they remain a penny stock. Wall Street's influence over the FDA assured big pharma MannKind would not receive a superior label and place the company on the cusp of bankruptcy. Alfred Mann probably believed the FDA would be fair in its evaluation of Afrezza, unfortunately he did not realize the greed and corruption that permeates the organization starting with Margaret Hamburg. That is the reason MannKind is in the situation it is in. |
|
|
|
Post by kbrion77 on Sept 1, 2016 10:18:27 GMT -5
Mannkind's problem is not Wallstreet. Their problem is lack of sales and revenue and a very uncertain future. If/when script numbers increase no argument or FUD can stop the moving train. Until then they remain a penny stock. Wall Street's influence over the FDA assured big pharma of a none superior label and the company on the cusp of bankruptcy. Alfred Mann probably believed the FDA would be fair in its evaluation of Afrezza, unfortunately he did not realize the greed and corruption that permeates the organization starting with Margaret Hamburg. That is the reason MannKind is in the situation it is in. MNKD management signed on the dotted line with Sanofi. Now we all know that wasn't the perfect marriage and who knows to the extent Sanofi bagged Afrezza but you have to put heat on MNKD management as well. This is business and it's managements responsibility to have plan B, C, D & E ready to go at any time. |
|
|
|
Post by tayl5 on Sept 1, 2016 10:31:08 GMT -5
All old news. Let's give the history a rest and focus what the company can do now to be successful.
|
|
|
|
Post by dictatorsaurus on Sept 1, 2016 10:35:55 GMT -5
Mannkind's problem is not Wallstreet. Their problem is lack of sales and revenue and a very uncertain future. If/when script numbers increase no argument or FUD can stop the moving train. Until then they remain a penny stock. Wall Street's influence over the FDA assured big pharma MannKind would not receive a superior label and place the company on the cusp of bankruptcy. Alfred Mann probably believed the FDA would be fair in its evaluation of Afrezza, unfortunately he did not realize the greed and corruption that permeates the organization starting with Margaret Hamburg. That is the reason MannKind is in the situation it is in. An extremely simplistic view of a massively complicated problem. To blame this mess on just the label is absurd. |
|
|
|
Post by saxcmann on Sept 1, 2016 10:42:11 GMT -5
Wall Street's influence over the FDA assured big pharma of a none superior label and the company on the cusp of bankruptcy. Alfred Mann probably believed the FDA would be fair in its evaluation of Afrezza, unfortunately he did not realize the greed and corruption that permeates the organization starting with Margaret Hamburg. That is the reason MannKind is in the situation it is in. MNKD management signed on the dotted line with Sanofi. Now we all know that wasn't the perfect marriage and who knows to the extent Sanofi bagged Afrezza but you have to put heat on MNKD management as well. This is business and it's managements responsibility to have plan B, C, D & E ready to go at any time. You're missing his point... Fda is manipulated by big pharma! Sanofi sandbagged afrezza! Wall Street is corrupt! Even if you had the perfect management team, it wouldn't matter. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Sept 1, 2016 10:45:34 GMT -5
yet all this could have been moot if $$$ were raised on fda approval - 50 mil shares @ 8 - when it was above 10
|
|
|
|
Post by peppy on Sept 1, 2016 11:25:37 GMT -5
The MannKind saga exemplifies Good versus Evil. Alfred Mann spent the majority of his life creating products for the betterment of mankind. Now with his greatest invention Afrezza and Technosphere, Wall Street is determined to bankrupt the company. Sad, very sad. Kastanes, you are so sad your picture disappeared, again. Just sayin
|
|
|
|
Post by babaoriley on Sept 1, 2016 11:33:07 GMT -5
yet all this could have been moot if $$$ were raised on fda approval - 50 mil shares @ 8 - when it was above 10 Hindsight is better than 20/20! Yes, raising more money when we had an "embarrassment of riches" - that would have really gone over big. Gee, I think I should have sold at $11, should have known the euphoria at the time was an absolute top signal. |
|
|
|
Post by Chris-C on Sept 1, 2016 12:09:21 GMT -5
I find it interesting that when someone points out that corruption and greed permeate the market, a chorus of replies often ensues suggesting that it is a company's fault for not anticipating and overcoming that corruption and greed— as though one should just regard such a state as the acceptable status quo. I don't believe Kastanes mentioned in his original post that it was Wall Street's fault that the company is a penny stock. He stated an opinion about a sad market characteristic that many share and lament. Al Mann had a beneficent vision; but often, it seems, no good deed goes unpunished. It is true that if we live in resignation that things will never change, whether in the market or in other facets of society, that belief will become a self-fulfilling prophecy.
|
|
|
|
Post by blindhog1 on Sept 1, 2016 12:32:56 GMT -5
All old news. Let's give the history a rest and focus what the company can do now to be successful. Oh My, Oh My I see nothing has changed during my absence.
Maybe if I stand in the middle of the room and shout "It works for me" 
Be Well
|
|
|
|
Post by kbrion77 on Sept 1, 2016 12:44:26 GMT -5
I find it interesting that when someone points out that corruption and greed permeate the market, a chorus of replies often ensues suggesting that it is a company's fault for not anticipating and overcoming that corruption and greed— as though one should just regard such a state as the acceptable status quo. I don't believe Kastanes mentioned in his original post that it was Wall Street's fault that the company is a penny stock. He stated an opinion about a sad market characteristic that many share and lament. Al Mann had a beneficent vision; but often, it seems, no good deed goes unpunished. It is true that if we live in resignation that things will never change, whether in the market or in other facets of society, that belief will become a self-fulfilling prophecy. Is that not a CEO's job? Every CEO has to deal with Wall St. and competition and yes MNKD probably more than others but it is their job. I'm not saying management should have anticipated everything that has happened to them but their job (specifically small bio-tech where cash will make or break you) is to have a plan for every angle and adapt to any scenario. |
|
|
|
Post by avogadro on Sept 1, 2016 13:35:04 GMT -5
All old news. Let's give the history a rest and focus what the company can do now to be successful. We need a pep song. This has nothing to do with insulin, but it may serve as an inspiration. Dig the ending:
Seeing their position, They called intermission And they heard the referee say: Seventeen to nothin' You're the one with nothin' And you've only got about a minute to play
THEN see what happens www.youtube.com/watch?v=hC-NJ7ywyHc
|
|
